Advertisement

Picture Demy-Colton BioFuture 2024 NYC 3 Biotech Breakthroughs 650x100px
Organisation › Details

Formycon AG (ISIN: DE000A1EWVY8/ WKN: A1EWVY)

Formycon is a leading, independent developer of high-quality biopharmaceutical medicines, especially biosimilars. The company focuses on treatments in ophthalmology, immunology and on other key chronic diseases, covering the entire value chain from technical development to the clinical phase III as well as the preparation of dossiers for marketing approval. With its biosimilars, Formycon is making a major contribution towards providing as many patients as possible with access to vital and affordable medicines. Formycon currently has four biosimilars in development. Based on its extensive experience in the developmentof biopharmaceutical drugs, the company is also working on the development of a COVID-19 fusion protein. *

 

Period Start 2012-09-01 renamed
  Group Formycon (Group)
  Predecessor Nanohale AG
Product Industry DRUGS, BIOGEN, GENERICS (biosimilars / biogenerics)
Persons Person Brockmeyer, Carsten (Formycon 201305 CEO)
  Person 2 Combé, Nicolas (Formycon CFO before Nanohale 201102 CFO)
     
Region Region Martinsried
  Country Germany
  Street 15 Fraunhoferstr.
  City 82152 Martinsried
  Tel +49-89-864667-100
    Address record changed: 2022-09-17
     
Basic data Employees C: 51 to 100 (2018-12-31)
  Currency EUR
  Annual sales 43,578,217 (revenue, consolidated (2018) 2018-12-31)
  Profit 7,098,615 (2018-12-31)
  Cash 7,336,154 (2018-12-31)
     
    * Document for »About Section«: Leukocare AG. (3/24/21). "Press Release: Leukocare and Formycon Cooperate in the Development of High-quality Biopharmaceuticals". Martinsried.
     
   
Record changed: 2024-01-30

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Game Changers 650x200px

More documents for Formycon (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Demy-Colton BioFuture 2024 NYC Reimagine Healthcare 650x300px




» top